125 related articles for article (PubMed ID: 8303670)
1. Thrombin treated plasma employed as a standard for determination of soluble fibrin.
Halvorsen S; Skjønsberg OH; Godal HC
Thromb Res; 1993 Nov; 72(4):305-13. PubMed ID: 8303670
[TBL] [Abstract][Full Text] [Related]
2. The stimulatory effect of soluble fibrin on plasminogen activation by tissue plasminogen activator as studied by the Coa-set Fibrin Monomer test.
Halvorsen S; Skjønsberg OH; Godal HC
Thromb Res; 1991 Feb; 61(4):453-61. PubMed ID: 1905851
[TBL] [Abstract][Full Text] [Related]
3. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay.
Wiman B; Rånby M
Thromb Haemost; 1986 Apr; 55(2):189-93. PubMed ID: 3087001
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methods for detecting soluble fibrin in plasma. An in vitro study.
Halvorsen S; Skjønsberg OH; Ruyter R; Godal HC
Thromb Res; 1990 Feb; 57(4):489-97. PubMed ID: 2326770
[TBL] [Abstract][Full Text] [Related]
5. Determination of soluble fibrin: a comparison of four different methods.
Wieding JU; Hosius C
Thromb Res; 1992 Mar; 65(6):745-56. PubMed ID: 1636166
[TBL] [Abstract][Full Text] [Related]
6. Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen.
Grøn B; Bennick A; Filion-Myklebust C; Matsueda GR; Nieuwenhuizen W; Brosstad F
Thromb Res; 1992 May; 66(2-3):231-8. PubMed ID: 1412194
[TBL] [Abstract][Full Text] [Related]
7. Soluble fibrin consists of fibrin oligomers of heterogeneous distribution.
Rötker J; Preissner KT; Müller-Berghaus G
Eur J Biochem; 1986 Mar; 155(3):583-8. PubMed ID: 3956500
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
Thiel W; Delvos U; Müller-Berghaus G
Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of blood coagulation by soluble fibrin complexes.
Hansen MS; Bang NU; Barton RD; Mattler LE
J Exp Med; 1975 May; 141(5):944-61. PubMed ID: 805207
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
[TBL] [Abstract][Full Text] [Related]
12. Studies on soluble fibrin in plasma. 3. N-terminal analysis of a modified fraction I (Cohn) from plasmin- and thrombin-incubated plasma.
Kierulf P
Scand J Clin Lab Invest; 1973 Jan; 31(1):43-9. PubMed ID: 4687776
[No Abstract] [Full Text] [Related]
13. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
[TBL] [Abstract][Full Text] [Related]
14. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
[TBL] [Abstract][Full Text] [Related]
15. Thrombin converts singlet oxygen (1O2)-oxidized fibrinogen into a soluble t-PA cofactor. A new method for preparing a stimulator for functional t-PA assays.
Stief TW; Kretschmer V; Kosche B; Doss MO; Renz H
Ann Hematol; 2001 Apr; 80(4):189-94. PubMed ID: 11401083
[TBL] [Abstract][Full Text] [Related]
16. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
[TBL] [Abstract][Full Text] [Related]
17. Formation of soluble fibrin oligomers in purified systems and in plasma.
Alkjaersig N; Fletcher AP
Biochem J; 1983 Jul; 213(1):75-83. PubMed ID: 6615433
[TBL] [Abstract][Full Text] [Related]
18. Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers.
Largo R; Heller V; Straub PW
Blood; 1976 Jun; 47(6):991-1002. PubMed ID: 132210
[TBL] [Abstract][Full Text] [Related]
19. Comparison of immunological and functional assays for measurement of soluble fibrin.
Dempfle CE; Pfitzner SA; Dollman M; Huck K; Stehle G; Heene DL
Thromb Haemost; 1995 Aug; 74(2):673-9. PubMed ID: 8585005
[TBL] [Abstract][Full Text] [Related]
20. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light.
Suontaka AM; Blombäck M; Chapman J
Transfusion; 2003 May; 43(5):568-75. PubMed ID: 12702176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
